Onconetix, Inc.
ONCONasdaqCIK 1782107HealthcareFiscal year ends Dec 31
Reports and events: 196 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2617:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-112527 |
| 2026-10-2311:40 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-111944 |
| 2026-10-0711:29 ET | DEF 14A | Proxy statementPeriod 2026-11-10 | 0001213900-26-107480 |
| 2026-09-1410:39 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-099524 |
| 2026-08-3116:05 ET | S-1/A | Registration statement, amended | 0001213900-26-095703 |
| 2026-08-1316:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-089093 |
| 2026-08-1213:52 ET | S-1 | Registration statement | 0001213900-26-087986 |
| 2026-07-2917:02 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-082879 |
| 2026-06-0917:44 ET | S-1 | Registration statement | 0001213900-26-066400 |
| 2026-05-1916:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-058997 |
| 2026-05-1420:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-056109 |
| 2026-05-1308:51 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-055483 |
| 2026-05-0715:33 ET | S-1/A | Registration statement, amended | 0001213900-26-053255 |
| 2026-05-0416:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-051575 |
| 2026-04-2816:05 ET | S-1 | Registration statement | 0001213900-26-048535 |
| 2026-04-2416:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-047577 |
| 2026-03-3008:47 ET | DEF 14A | Proxy statementPeriod 2026-04-30 | 0001213900-26-035976 |
| 2026-03-2718:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-034902 |
| 2026-03-2516:05 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-034054 |
| 2026-03-2417:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-033643 |
| 2026-03-1316:47 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-027725 |
| 2026-02-1208:12 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-015212 |
| 2026-02-0917:00 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-013724 |
| 2026-01-0209:32 ET | DEF 14A | Proxy statementPeriod 2026-02-03 | 0001213900-26-000080 |
| 2025-12-2218:50 ET | S-1/A | Registration statement, amended | 0001213900-25-124018 |
| 2025-12-1017:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-120144 |
| 2025-12-1009:28 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-119898 |
| 2025-11-1317:26 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-110142 |
| 2025-11-1013:26 ET | DEF 14A | Proxy statementPeriod 2025-12-05 | 0001213900-25-108093 |
| 2025-11-0416:40 ET | S-1 | Registration statement | 0001213900-25-106177 |
| 2025-10-2912:17 ET | 8-K | 5.08 Item not in the standard list | 0001213900-25-103351 |
| 2025-10-1621:24 ET | S-1 | Registration statement | 0001213900-25-099298 |
| 2025-10-0308:16 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-095847 |
| 2025-09-2608:45 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-091966 |
| 2025-09-2208:37 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-089845 |
| 2025-09-0416:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-25-084500 |
| 2025-08-1407:32 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-076032 |
| 2025-08-1216:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-074952 |
| 2025-07-1616:03 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-019830 |
| 2025-07-1608:37 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-064469 |
| 2025-06-1608:40 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-054501 |
| 2025-06-1217:16 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-053914 |
| 2025-06-1113:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-053367 |
| 2025-06-0516:12 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-051573 |
| 2025-06-0207:41 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001213900-25-049687 |
| 2025-05-2217:10 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-25-046909 |
| 2025-04-3017:23 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-25-037765 |
| 2025-04-3018:50 ET | DEF 14A | Proxy statementPeriod 2025-05-30 | 0001213900-25-036959 |
| 2025-04-1814:30 ET | 8-K | 3.01 Delisting notice; 8.01 Other events | 0001213900-25-033295 |
| 2025-04-0809:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-029639 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 08:32 ET. Listed shows no prices and gives no investment advice.